An analysis of our cohort and the public ACC pediatric dataset GSE76019 showed that lower PRKAB2 expression was associated with relapse, death, metastasis, and lower event-free and overall survival rates. The gene discussed is PRKAB2; the disease is adrenal cortex carcinoma.